Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -156.69% is 28% below its 5-year average of -122.62%, near the high end of its 5-year range (-1195.68%–-37.87%).
As of the fiscal period ended Friday, July 31, 2026. 59.31% above its 12-month average of -385.08%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-07-31): -156.69%.
RETURN ON INVESTED CAPITAL (ROIC)
-156.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-385.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-289.50%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-122.62%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+59.31%
CURRENT VS 3Y AVG
+45.88%
CURRENT VS 5Y AVG
-27.78%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-339.39%
vs the sector median at left
Alzamend Neuro Inc
Market Cap
$5.21M
Return on Invested Capital (ROIC)
-156.69%
TTM Avg
-385.08%
3Y Avg
-289.50%
5Y Avg
-122.62%
Market Cap
$5.21M
Return on Invested Capital (ROIC)
-35.07%
TTM Avg
-9.54%
3Y Avg
2.54%
5Y Avg
2.54%
Market Cap
$5.22M
Return on Invested Capital (ROIC)
-160.81%
TTM Avg
-121.99%
3Y Avg
-86.44%
5Y Avg
-69.30%
Market Cap
$5.24M
Return on Invested Capital (ROIC)
-179.58%
TTM Avg
-259.96%
3Y Avg
-220.56%
5Y Avg
-170.22%
Market Cap
$5.12M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-67.32%
3Y Avg
-73.33%
5Y Avg
-73.33%
Market Cap
$5.31M
Return on Invested Capital (ROIC)
-161.69%
TTM Avg
-192.94%
3Y Avg
-175.58%
5Y Avg
-149.58%
Market Cap
$5.32M
Return on Invested Capital (ROIC)
-27.41%
TTM Avg
-21.46%
3Y Avg
-17.98%
5Y Avg
-12.44%
Market Cap
$5.35M
Return on Invested Capital (ROIC)
-175.26%
TTM Avg
-258.55%
3Y Avg
-208.94%
5Y Avg
-173.09%
Market Cap
$4.97M
Return on Invested Capital (ROIC)
-225.12%
TTM Avg
-13.17%
3Y Avg
-9.09%
5Y Avg
-9.09%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alzamend Neuro Inc (ALZN) | $5.21M | -156.69% | -385.08% | -289.50% | -122.62% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.21M | -35.07% | -9.54% | 2.54% | 2.54% |
| Pulmatrix, Inc. (PULM)vs › | $5.22M | -160.81% | -121.99% | -86.44% | -69.30% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.24M | -179.58% | -259.96% | -220.56% | -170.22% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.12M | N/A | -67.32% | -73.33% | -73.33% |
| Soligenix, Inc. (SNGX)vs › | $5.31M | -161.69% | -192.94% | -175.58% | -149.58% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.32M | -27.41% | -21.46% | -17.98% | -12.44% |
| Lexaria Bioscience Corp. (LEXX)vs › | $5.35M | -175.26% | -258.55% | -208.94% | -173.09% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $4.97M | -225.12% | -13.17% | -9.09% | -9.09% |
| Xenetic Biosciences, Inc. (XBIO)vs › | $4.86M | -43.50% | -54.16% | -50.91% | -58.12% |
ROIC
-156.7%
ROE
-156.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-07-31 | -156.69% |
| 2026-04-30 | -1195.68% |
| 2026-01-31 | -322.04% |
| 2025-10-31 | -134.30% |
| 2025-07-31 | -116.68% |
| 2025-04-30 | -113.32% |
| 2025-01-31 | -121.98% |
| 2024-10-31 | -155.36% |
| 2023-04-30 | -488.28% |
| 2023-01-31 | -263.47% |
| 2022-10-31 | -143.06% |
| 2022-07-31 | -116.70% |
| 2022-04-30 | -92.27% |
| 2022-01-31 | -80.81% |
| 2021-10-31 | -61.52% |
| 2021-07-31 | -37.87% |
| 2021-04-30 | -210.88% |
| 2020-04-30 | -500.27% |
| 2019-10-31 | -164.35% |
| 2019-07-31 | -191.45% |
| 2019-04-30 | -1263.85% |
| 2019-01-31 | -1109.91% |
| 2018-10-31 | -242.49% |
| 2018-07-31 | -150.05% |
| 2018-04-30 | -38.80% |
| 2018-01-31 | -41.57% |
| 2017-10-31 | -470.55% |
| 2017-07-31 | -589.58% |
